About Vintas Pharmaceuticals Private Limited
Data last updated:
Vintas Pharmaceuticals Private Limited is a private limited company based in Ambala, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 July 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397HR2015PTC056046. Its GSTIN is 06AAFCV1722Q1Z0 (Haryana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Munish Aggarwal and Rahul Saini.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at #165 Sena Nagar Markandey Complex P.O Dhulkot, Ambala, Haryana, India – 134003.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.44 Cr, a decline of 5% compared to the previous year. For the same year it recorded a net profit of ₹2.2 Lakh (net margin 0.9%) and EBITDA of ₹3.77 Lakh (EBITDA margin 1.5%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 1% over five years.
Court records list 14 cases involving the company, including 14 filed by the company; 4 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vintaspharma.com.
Company details
Contact details
Vintas Pharmaceuticals Private Limited's registered office is in Ambala, Haryana. Its website is vintaspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address#165 Sena Nagar Markandey Complex P.O Dhulkot, Ambala, Haryana, India – 134003
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Vintas Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Vintas Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Vintas Pharmaceuticals Private Limited, buy the company report.
Financials of Vintas Pharmaceuticals Private Limited
FY 2025 filings availableVintas Pharmaceuticals Private Limited reported revenue of ₹2.44 Cr (down 5% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 5% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 1%. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.77 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.2 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.5% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vintas Pharmaceuticals Private Limited, buy the company report.
Board of directors of Vintas Pharmaceuticals Private Limited
Vintas Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Munish Aggarwal | Director | 14 Jul 2015 | 11 Years 3 Months | Current |
| Rahul Saini | Director | 14 Jul 2015 | 11 Years 3 Months | Current |
| Varesh Khanna Also directs: Alisier Drugs Private Limited, Shinor Herbals Private Limited, Shinor Biosciences Private Limited and 1 more | Director | 14 Jul 2015 | 11 Years 3 Months | Current |
Peer comparison
Vintas Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dolphar Life Care Private Limited | ₹2.46 Cr (FY 2024) | Chandigarh, India | ||||
| Suncure Lifescience Private Limited | ₹2.45 Cr (FY 2025) | 26.0% | Surat, Gujarat, India | |||
| Vintas Pharmaceuticals Private Limitedthis company | ₹2.44 Cr (FY 2025) | ₹2.2 Lakh | 0.9% | -5.0% | Ambala, Haryana, India | |
| Unitas Healthcare Private Limited | ₹2.44 Cr (FY 2025) | 5.0% | New Delhi, Delhi, India | |||
| Om Shubham Pharmaceuticals Private Limited | ₹2.43 Cr (FY 2024) | -23.0% | Kanpur, Uttar Pradesh, India | |||
| Clara Pharmachem Private Limited | ₹2.43 Cr (FY 2025) | 27.0% | Palghar, Maharashtra, India |
To see the full peer comparison of Vintas Pharmaceuticals Private Limited, buy the company report.
Auditor
Vintas Pharmaceuticals Private Limited is audited by GNRA & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GNRA & CO. | FY 2023 | 019674N |
Shareholding
The shareholding of Vintas Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Vintas Pharmaceuticals Private Limited, buy the company report.
Legal cases
Vintas Pharmaceuticals Private Limited has 14 court cases on record: 14 filed by Vintas Pharmaceuticals. 4 cases are pending and 10 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 14 | 0 | 4 |
Cases on record (5 of 14)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ambala, Haryana | Commercial suit | Filed by the company against M/S Saar Life Sciences Pvt. Ltd. and 1 other | Disposed |
| District court, Ambala, Haryana | Cheque dishonour complaint | Filed by the company against M/S True Mads Pharma | Pending |
| District court, Ambala, Haryana | Cheque dishonour complaint | Filed by the company against Shree Guru Pharma | Pending |
| District court, Ambala, Haryana | Cheque dishonour complaint | Filed by the company against M/S R R Enterprises Pharmaceuticals Distributors and 1 other | Pending |
| District court, Ambala, Haryana | Cheque dishonour complaint | Filed by the company against M/S MJS Pharma and 1 other | Pending |
To see the full case history of Vintas Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Vintas Pharmaceuticals Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 7 overdue payments to 6 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 6)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| MMG Healthcare Sirmour | |||
| Shivam Enterprises Sirmour (H.P.) | |||
| Alps Communication Private Limited | |||
| an individual supplier | |||
| MMG Healthcare Sirmour |
To see the full MSME payment records of Vintas Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Vintas Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAFCV1722Q1Z0 | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Vintas Pharmaceuticals Private Limited, buy the company report.
Recent activity
Vintas Pharmaceuticals Private Limited has 3 board changes on record since 2015: 3 appointments. The latest: Munish Aggarwal was appointed as Director on 14 Jul 2015.
Frequently asked questions
Vintas Pharmaceuticals is an active private limited company based in Ambala, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 July 2015 (11+ years old) and is registered under CIN U51397HR2015PTC056046.
Vintas Pharmaceuticals has 3 current directors:
- Munish Aggarwal - Director
- Rahul Saini - Director
- Varesh Khanna - Director
The latest financial statements of Vintas Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Vintas Pharmaceuticals is 06AAFCV1722Q1Z0, registered in Haryana.
The CIN (Corporate Identification Number) of Vintas Pharmaceuticals is U51397HR2015PTC056046. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vintas Pharmaceuticals has 14 court cases on record: 14 filed by the company. 4 are pending.
Vintas Pharmaceuticals was incorporated on 14 July 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Vintas Pharmaceuticals by revenue are Dolphar Life Care Private Limited, Suncure Lifescience Private Limited, Unitas Healthcare Private Limited, Om Shubham Pharmaceuticals Private Limited, Clara Pharmachem Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Munish Aggarwal was appointed as Director on 14 Jul 2015. Rahul Saini was appointed as Director on 14 Jul 2015. Varesh Khanna was appointed as Director on 14 Jul 2015.
Vintas Pharmaceuticals has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 7 overdue payments to 6 micro and small suppliers. The latest return was filed on 30 May 2019.
Vintas Pharmaceuticals can be reached through the website vintaspharma.com. Its registered office is in Ambala, Haryana, India.
The registered office of Vintas Pharmaceuticals is at #165 Sena Nagar Markandey Complex P.O Dhulkot, Ambala, Haryana, India – 134003.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
